Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Dimitrios Alexandris"'
Publikováno v:
Advances in Cancer Biology - Metastasis, Vol 6, Iss , Pp 100078- (2022)
Cutaneous Metastases, a rare clinical manifestation of great importance, arise critical differential diagnostic dilemmas among physicians, as it can easily masquerade into various forms. Besides histological confirmation, a few research has been cond
Externí odkaz:
https://doaj.org/article/7d0aed268c4b48e7bd36c1a653303d3e
Autor:
Kostas Palamaris, Dimitrios Alexandris, Kostas Stylianou, Ioannis Giatras, Anastasios Stofas, Christina Kaitatzoglou, Magda Migkou, Dimitrios Goutas, Erasmia Psimenou, Eleni Theodoropoulou, Stamatios Theocharis, Nektarios Alevizopoulos, Efstathios Kastritis, Alexandros Gerakis, Harikleia Gakiopoulou
Publikováno v:
Journal of Clinical Medicine, Vol 11, Iss 16, p 4786 (2022)
We present a series of twelve patients, bearing a wide range of solid malignancies, who received either PD-L1 or a combination of PD-L1 and CTLA-4 inhibitors. Following immunotherapy administration, they exhibited the clinical signs indicative of ren
Externí odkaz:
https://doaj.org/article/733ad7a3c2394ccf9806d50130ecac49
Autor:
Dimitrios Alexandris, Nektarios Alevizopoulos, Leonidas Marinos, Georgios Kanellis, Charikleia Gakiopoulou
Publikováno v:
Journal of Oncology Pharmacy Practice. 29:252-257
Introduction Imatinib Mesylate (IM), a tyrosine kinase inhibitor, has been reported to cause several adverse reactions, most of them with cutaneous involvement. Non- Lichenoid IM associated skin reactions have been sufficiently- recorded. To our know
Autor:
Dimitrios Alexandris, Nektarios Alevizopoulos, Kostas Palamaris, Charikleia Gakiopoulou, Stamatios Theocharis
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.
Introduction Anti-EGFR targeted anti-cancer treatment is associated with various skin adverse events. Cetuximab is often associated with acneiform papules and skin disorders. Hypertrichosis cited in face pinnae and eyelash trichomegaly are seldom des
Autor:
Dimitrios Alexandris, Nektarios Alevizopoulos, Harikleia Gakiopoulou, Nikolina Stavrinou, Christine Vourlakou
Publikováno v:
Journal of Oncology Pharmacy Practice. :107815522210746
Introduction: New Immuno- Checkpoint inhibitors (ICIs) functioning as PD-1- PDL-1 blockers are nowadays used in a majority of anticancer treatments. Many immune- related Adverse Events (irAEs) are published daily; severe skin toxicities, Stevens John
Autor:
Nektarios Alevizopoulos, Dimitrios Alexandris, Michael Pavlakis, Areti Dimitriadou, Konstantinos Folinas, Helen Kammenou
Publikováno v:
The Breast. 59:S63